The neurotoxicity of dapsone.
D000293:Adolescent; D000328:Adult; D000818:Animals; D002648:Child; D003622:Dapsone / Q000009:adverse effects* / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis / Q000139:chemically induced; D004594:Electrophysiology / Q000187:drug effects; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007918:Leprosy / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D009132:Muscles / Q000187:drug effects; D009475:Neurons, Afferent / Q000187:drug effects; D010525:Peripheral Nerves / Q000187:drug effects; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D011596:Psychomotor Disorders / Q000139:chemically induced; D011605:Psychoses, Substance-Induced / Q000209:etiology; D051381:Rats; D012018:Reflex / Q000187:drug effects; D014786:Vision Disorders / Q000139:chemically induced
D003622:Dapsone